The myelodysplastic syndromes (MDS) are a heterogenous group of disorders characterized by clonal expansion of hematopoietic cells. Cytopenias and transformation to acute myeloid leukemia are important sequelae of MDS. The genetic basis of these disorders is poorly understood. The longterm goal of this project is to identify and characterize new mutations that are important for MDS initiation and progression. We propose to conduct a large-scale study of the genomics of MDS, utilizing high-throughput resequencing and array-based comparative genomic hybridization to identify novel genetic changes in samples from patients with MDS. We have also produced a unique mouse model of alkylator-induced MDS that will complement the search for mutations that are important for human MDS. We have several key resources available that make this project feasible, including a bank of matched tumor and germline (skin) samples from MDS patients, a close collaboration with the Washington University Genome Sequencing Center, prevalidated primers for all the genes selected for resequencing, and custom-produced bacterial artificial chromosome (BAG) arrays representing the complete tiling paths for the mouse and human genomes. With these resources in hand, we propose the following specific aims:
Specific Aim 1 : We will utilize highthroughput DMA sequencing and comparative genomic hybridization to identify genetic changes in samples from patients with myelodysplastic syndromes.
Specific Aim 2 : We will utilize a mouse model of t-MDS to identify and characterize novel mutations associated with the development of myelodysplastic syndromes.
These Aims are complementary and are structured to provide independent validation for the mutations we find. Although the goals of this project are primarily mutation discovery, we will utilize standard in vitro and in vivo assays to confirm the biological consequences of the mutations we discover. All genetic data that we obtain in these studies will be deposited in publicly accessible databases in a format that will be useful to other investigators. Lay Audience Summary: We propose to use several unique resources available at our institution to discover new information about the genetic basis of the myelodysplastic syndromes. These findings should improve our ability to predict the prognosis of patients with MDS and provide a rational basis for designing specific therapies that are more effective and less toxic.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL082973-03
Application #
7279208
Study Section
Special Emphasis Panel (ZHL1-CSR-I (S1))
Program Officer
Di Fronzo, Nancy L
Project Start
2005-09-15
Project End
2009-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
3
Fiscal Year
2007
Total Cost
$507,752
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Walter, M J; Shen, D; Shao, J et al. (2013) Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia 27:1275-82
Walter, Matthew J; Shen, Dong; Ding, Li et al. (2012) Clonal architecture of secondary acute myeloid leukemia. N Engl J Med 366:1090-8
Chen, Tim H-P; Kambal, Amal; Krysiak, Kilannin et al. (2011) Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice. Blood 117:1530-9
Walter, M J; Ding, L; Shen, D et al. (2011) Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 25:1153-8
Graubert, Timothy A; Shen, Dong; Ding, Li et al. (2011) Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat Genet 44:53-7
Graubert, Timothy (2010) Therapy-related myelodysplastic syndrome: models and genetics. Biol Blood Marrow Transplant 16:S45-7
Martin, M G; Welch, J S; Uy, G L et al. (2010) Limited engraftment of low-risk myelodysplastic syndrome cells in NOD/SCID gamma-C chain knockout mice. Leukemia 24:1662-4
Cahan, Patrick; Li, Yedda; Izumi, Masayo et al. (2009) The impact of copy number variation on local gene expression in mouse hematopoietic stem and progenitor cells. Nat Genet 41:430-7
Graubert, Timothy A; Payton, Michelle A; Shao, Jin et al. (2009) Integrated genomic analysis implicates haploinsufficiency of multiple chromosome 5q31.2 genes in de novo myelodysplastic syndromes pathogenesis. PLoS One 4:e4583